Talk:Tick-borne encephalitis vaccine
Appearance
![]() | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tick-borne encephalitis vaccine.
|
The citation on the statistic that “More than 87% of people who receive the vaccine develop immunity” appears to be misleading after reading the cited paper. The paper states that all participants had a reaction to the vaccine and zero cases were reported of the vaccinated population, but that actual immunity wasn’t directly tested. The 87% figure seems to come from a titer measurement, not an immunity measurement. It seems likely that the vaccine is much more effective than this statistic would hint at, giving the “more than” phrase a lot of carrying weight. However, I’m not an immunologist and would love to have an expert take a look. --Sam (talk) 15:29, 1 August 2024 (UTC)
Categories:
- C-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- C-Class medicine articles
- Mid-importance medicine articles
- C-Class WikiProject Medicine Translation Task Force articles
- High-importance WikiProject Medicine Translation Task Force articles
- WikiProject Medicine Translation Task Force articles
- All WikiProject Medicine pages